Drug Shortage Report for ZYCLARA
| Report ID | 237210 |
| Drug Identification Number | 02340445 |
| Brand name | ZYCLARA |
| Common or Proper name | ZYCLARA |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | IMIQUIMOD |
| Strength(s) | 3.75% |
| Dosage form(s) | CREAM |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 7.5g |
| ATC code | D06BB |
| ATC description | CHEMOTHERAPEUTICS FOR TOPICAL USE |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-11-01 |
| Actual start date | 2024-11-05 |
| Estimated end date | 2025-08-08 |
| Actual end date | 2025-08-05 |
| Shortage status | Resolved |
| Updated date | 2025-08-06 |
| Company comments | delay in production |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.